Antibody-dependent, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 5287-5290

  Perez, Lautaro ^a   Zolla Pazner, Susan ^b,c   Montefiori, David C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; COMPLEMENTARY DNA; EPITOPE; FC GAMMA RECEPTOR I; FC RECEPTOR; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G1B12 ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 4E10; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ASSAY; CELL PHAGOCYTOSIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; VIRUS ATTACHMENT; VIRUS NEUTRALIZATION; VIRUS PARTICLE;

ANTIBODIES, NEUTRALIZING; CELL LINE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; NEUTRALIZATION TESTS; PHAGOCYTOSIS; RECEPTORS, IGG;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84876327869     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00278-13     Document Type: Article

References (42)

1. Nimmerjahn F, Ravetch JV. 2006. Fcγ receptors:old friends and new family members. Immunity. 24:19-28
2. Nimmerjahn F, Ravetch JV. 2008. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8:34-47
3. Montefiori DC. 1997. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection. Springer Semin. Immunopathol. 18:371-390
4. Ackerman ME, Moldt B, Wyatt RT, Dugast A-S, McAndrew E, Tsoukas S, Jost S, Berger CT, Sciaranghella G, Liu Q, Irvine DJ, Burton DR, Alter G. 2011. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. J. Immunol. Methods 366:8-19
5. Holl V, Peressin M, Schmidt S, Decoville T, Zolla-Pazner S, Aubertin A-M, Moog C. 2006. Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation. Blood 107:4466-4474.
6. Holl V, Peressin M, Decoville T, Schmidt S, Zolla-Pazner S, Aubertin A-M, Moog C. 2006. Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type l replication in macrophages and immature dendritic cells. J. Virol. 80:6177-6181
7. Perez LG, Costa MR, Todd CA, Haynes BF, Montefiori DC. 2009. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1:a specific role for antibodies against the membraneproximal external region of gp41. J. Virol. 83:7397-7410
8. Hessell AJ, Rakasz EG, Tehrani DM, Huber M, Weisgrau KL, Landucci G, Forthal DN, Koff WC, Poignard P, Watkins DI, Burton DR. 2010. Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type I gp41 membraneproximal external region protect against mucosal challenge by simianhuman immunodeficiency virus SHIVBa-L. J. Virol. 84:1302-1313
9. Byrne GI, Moulder JW. 1978. Parasite-specific phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells. Infect. Immun. 19:598-606
10. Clerc P, Sansonetti PJ. 1987. Entry of Shigella flexneri into HeLa cells:evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect. Immun. 55:2681-2688
11. Guzmán-Verri C, Chaves-Olarte E, von Eichel-Streiber C, López-Goňi I, Thelestam M, Arvidson S, Gorvel J-P, Moreno E. 2001. GTPases of the Rho subfamily are required for Brucella abortus internalization of nonprofessional phagocytes. J. Biol. Chem. 276:44435-44443
12. Giodini A, Rahner C, Cresswell P. 2009. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. Proc. Natl. Acad. Sci. U. S. A. 106:3324-3329
13. Hunter S, Kamoun M, Schreiber A. 1994. Transfection of an Fc receptor cDNA induces T cells to become phagocytic. Proc. Natl. Acad. Sci. U. S. A. 91:10232-10236
14. Indik Z, Kelli C, Chien P, Levinson AI, Schreiber AD. 1991. Human FcγRII, in the absence of other Fcγ receptors, mediates a phagocytic signal. J. Clin. Invest. 88:1766-1771
15. Kinchen JM, Ravichandran KS. 2008. Phagosome maturation:going through the acid test. Nat. Rev. Mol. Cell. Biol. 9:781-795
16. Matsuzawa Y, Hostetler KY. 1980. Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4=-bis(diethylaminoethoxy)α,β-diethyldiphenylethane. J. Biol. Chem. 255:5190-5194
17. Ohkuma S, Poole B. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. U. S. A. 75:3327-3331
18. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266:17707-17712
19. Zhang Y, Hoppe AD, Swanson JA. 2010. Coordination of Fc receptor signaling regulates cellular commitment to phagocytosis. Proc. Natl. Acad. Sci. U. S. A. 107:19332-19337
20. Bergamaschi A, David A, Le Rouzic E, Nisole S, Barré-Sinoussi F, Pancino G. 2009. The CDK inhibitor p21Cip1/WAF1 is induced by FcγR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J. Virol. 83:12253-12265
21. Labrijn AF, Poignard P, Raja A, Zwick MB, Delgado K, Franti M, Binley J, Vivona V, Grundner C, Huang CC, Venturi M, Petropoulos CJ, Wrin T, Dimitrov DS, Robinson J, Kwong PD, Wyatt RT, Sodroski J, Burton DR. 2003. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J. Virol. 77:10557-10565
22. Bou-Habib DC, Roderiquez G, Oravecz T, Berman PW, Lusso P, Norcross MA. 1994. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68:6006-6013
23. Frey G, Peng H, Rits-Volloch S, Morelli M, Cheng Y, Chen B. 2008. A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies. Proc. Natl. Acad. Sci. U. S. A. 105:3739-3744
24. Gustchina E, Bewley CA, Clore GM. 2008. Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41. J. Virol. 82:10032-10041
25. Wyatt R, Sodroski J. 1998. The HIV-1 envelope glycoproteins:fusogens, antigens, and immunogens. Science 280:1884-1888
26. Zwick MB, Komori HY, Stanfield RL, Church S, Wang M, Parren PWHI, Kunert R, Katinger H, Wilson IA, Burton D. 2004. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. J. Virol. 78:3155-3161
27. Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall DJ, Chen B, Parks R, Foulger A, Jaeger FM, Donathan M, Bilska M, Grey ES, Abdool Karim SS, Kepler TB, Whitesides J, Montefiori D, Moody MA, Liao H-X, Haynes BF. 2011. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single cell sorting. PLoS One 6:e23532. doi:10.1371/journal.pone.0023532.
28. Zhu Z, Qin HR, Chen W, Zhao Q, Shen X, Schute R, Wang Y, Ofek G, Streaker E, Prabakaran P, Fouda GG, Liao H-X, Owens J, Louder M, Yang Y, Klaric K-A, Moody MA, Mascola JR, Scott JK, Kwong PD, Montefiori D, Haynes BF, Tomaras GD, Dimitrov DS. 2011. Crossreactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J. Virol. 85:11401-11408
29. Gorny MK, VanCott TC, Williams C, Revesz K, Zolla-Pazner S. 2000. Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins. Virology 267:220-228
30. Nyambi PN, Mbah HA, Burda S, Williams C, Gorny MK, Nadas A, Zolla-Pazner S. 2000. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J. Virol. 74:7096-7107
31. Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, Williams C, Burda S, Boots LJ, Zolla-Pazner S. 1994. Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of HIV-1. J. Virol. 68:8312-8320
32. Gorny MK, Pan R, Williams C, Wang XH, Volsky B, O'Neal T, Spurrier B, Sampson JM, Li L, Seaman MS, Kong XP, Zolla-Pazner S. 2012. Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from human immunodeficiency virus type 1-infected individuals. Virology 427:198-207
33. Gorny MK, Williams C, Volsky B, Revesz K, Cohen S, Polonis VR, Honnen WJ, Kayman SC, Krachmarov CP, Pinter A, Zolla-Pazner S. 2002. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize HIV-1 primary isolates from various clades. J. Virol. 76:9035-9045
34. Gorny MK, Wang XH, Williams C, Volsky B, Revesz K, Witover B, Burda S, Urbanski M, Nyambi P, Krachmarov C, Pinter A, Zolla-Pazner S, Nadas A. 2009. Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol. Immunol. 46:917-926
35. Gorny MK, Xu J-Y, Karwowska S, Buchbinder A, Zolla-Pazner S. 1993. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150:635-643
36. Gorny MK, Williams C, Volsky B, Revesz K, Wang XH, Burda S, Kimura T, Koning FA, Nadas A, Anyangwe C, Nyambi P, Krachmarov C, Pinter A, Zolla-Pazner S. 2006. Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of HIV-1. J. Virol. 80:6865-6872
37. Nyambi PN, Gorny MK, Bastiani L, van der Groen G, Williams C, Zolla-Pazner S. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions:a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 72:9384-9391
38. Jeffs SA, Gorny MK, Williams C, Revesz K, Volsky B, Burda S, Wang XH, Bandres J, Zolla-Pazner S, Holmes H. 2001. Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120. Immunol. Lett. 79:209-213
39. Zolla-Pazner S, O'Leary J, Burda S, Gorny MK, Kim M, Mascola J, McCutchan FE. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69:3807-3815
40. Xu J-Y, Gorny MK, Palker T, Karwowska S, Zolla-Pazner S. 1991. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J. Virol. 65:4832-4838
41. Gorny MK, Gianakakos V, Sharpe S, Zolla-Pazner S. 1989. Generation of human monoclonal antibodies to HIV. Proc. Natl. Acad. Sci. U. S. A. 86:1624-1628
42. Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, Conway JA, Wieczorek L, Brown B, Polonis V, West JT, Montefiori DC, Kappes JC, Ochsenbauer C. 2010. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology 408:1-13